• EDUCATION

2019 CSHP/SH Joint Workshop Presentations

The 1st Joint Chinese Society for Hematopathology (CSHP) and Society for Hematopathology (SH) Workshop took take place on October 19 – 20, at the Gran Meliá Hotel in Xi'an, China. The topic of the Joint Workshop was "Infectious agent-associated lymphoid proliferations". Unique to this Joint Workshop, there was a session designated for Multidisciplinary Case Discussions. This Joint Workshop was a historic event, which symbolized the beginning of scientific collaborations between the two societies.

The Workshop focused on the following goals and overarching objectives:

1). Illustrate overlapping features and diagnostic challenges of IALP, including borderline conditions between reactive lymphoproliferations and lymphomas, as well as various subtypes of infectious agent-associated lymphomas;

2). Elucidate and expand the diagnostic criteria set by the current WHO classification systems;

3). Recognize host susceptibility factors including molecular markers in the development and progression of IALP;

4). Develop consensus recommendations in approaches of distinguishing highly aggressive IALP from indolent forms, including conditions related to chronic active EBV infections.

Keynote & Plenary Presentations


Watch Video
| 42 minutes

KEYNOTE - Viral lymphomagenesis, host susceptibility and update on vaccines against lymphomagenic viruses.
Dr. Richard Longnecker, Northwestern University, Chicago, IL, USA


Watch Video
| 30 minutes

EBV positive T/NK cell lymphoprolifertive diseases in China
Dr. Zhou Xiaoge, Beijing Friendship Hospital, Capital Medical University, Beijing, China


Watch Video
| 34 minutes

HIV and KSHV/HHV8-Related Lymphomas and Lymphoproliferative Lesions
Dr. Amy Chadburn, Weill Cornell


Watch Video
| 39 minutes

EBV‐related B‐cell lymphomas, non‐PTLD type
Dr. John Goodlad, NHS Greater Glasgow and Clyde/University of Glasgow, QEUH & Beatson/Gartnavel Hospitals


Watch Video
| 46 minutes

HIV‐Associated Lymphomas in 2019: Spectrum of Disease and Treatment Approach
Dr. Paul Rubinstein, Stroger Hospital of Cook County, Rush University Medical Center